O'Shaughnessy Asset Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

O'Shaughnessy Asset Management’s Portfolio SCLN Stock Details SCLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-33,844	Closed	-$366K	–	1012
2016 Q4	$366K	Sell	33,844 -4,574	-12%	-$45.7K	0.01%	415
2016 Q3	$394K	Hold	38,418	–	–	0.01%	374
2016 Q2	$502K	Buy	38,418 +35,655	+1,290%	+$467K	0.01%	338
2016 Q1	$27K	Buy	2,763 +9	+0.3%	+$80	﹤0.01%	642
2015 Q4	$25K	Buy	2,754 +191	+7%	+$1.6K	﹤0.01%	653
2015 Q3	$18K	Buy	2,563 +1,524	+147%	+$13.1K	﹤0.01%	650
2015 Q2	$10K	Buy	+1,039	New	+$9.46K	﹤0.01%	751

Other funds holding SCLN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

O'Shaughnessy Asset Management's SCLN Position: Q1 2017 in Review

O'Shaughnessy Asset Management sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q1 2017, closing a stake of 33,844 shares — an estimated $366K sold.

O'Shaughnessy Asset Management first reported a position in SCLN in Q2 2015 and held it in 7 quarters. The position peaked at $502K in Q2 2016. 136 funds tracked by Wall St. Rank hold SCLN as of Q1 2017.

O'Shaughnessy Asset Management reported no remaining Sciclone Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
O'Shaughnessy Asset Management sold 33,844 Sciclone Pharmaceuticals Inc shares in Q1 2017, an estimated $366K.
O'Shaughnessy Asset Management first reported a position in Sciclone Pharmaceuticals Inc in Q2 2015 and held it in 7 quarters.
O'Shaughnessy Asset Management's Sciclone Pharmaceuticals Inc position peaked at $502K in Q2 2016.
136 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q1 2017.

Based on O'Shaughnessy Asset Management's 13F filing for Q1 2017, filed 11 May 2017.